Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Joo Cho

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 27, 2017
Effect of Epiretinal Membranes on Antivascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular DegenerationHan Joo Cho, Jae Min Kim, Hyoung Seok Kim, et al.
Scientific Reports|September 15, 2021
Author Correction: Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathyJihyun Yoon, Wontae Yoon, Seung Kwan Na, et al.
American Journal of Ophthalmology|April 7, 2016
Response of Pigment Epithelial Detachment to Anti-Vascular Endothelial Growth Factor Treatment in Age-Related Macular DegenerationHan Joo Cho, Kyoung Min Kim, Hyoung Seok Kim, et al.
Retina (Philadelphia, Pa.)|October 7, 2017
INTRAVITREAL AFLIBERCEPT AND RANIBIZUMAB INJECTIONS FOR TYPE 3 NEOVASCULARIZATIONHan Joo Cho, Hyun Ji Hwang, Hyoung Seok Kim, et al.
Retina (Philadelphia, Pa.)|April 24, 2013
Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for polypoidal choroidal vasculopathyHan Joo Cho, Ji Sun Baek, Dong Won Lee, et al.
American Journal of Ophthalmology|June 18, 2013
Anti-vascular endothelial growth factor monotherapy in the treatment of submacular hemorrhage secondary to polypoidal choroidal vasculopathyHan Joo Cho, Kyung Min Koh, Hyoung Seok Kim, et al.
Scientific Reports|June 9, 2021
Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathyJihyun Yoon, Wontae Yoon, Seung Kwan Na, et al.
Acta Ophthalmologica|September 30, 2020
Progression of macular atrophy in patients undergoing anti-vascular endothelial growth factor therapy for neovascular age-related macular degenerationHan Joo Cho, Sang Min Park, Jaemin Kim, et al.
Korean Journal of Ophthalmology : KJO|August 21, 2022
Immediate Vitrectomy for Acute Endophthalmitis in Patients with a Visual Acuity of Hand Motion or BetterJaemin Kim, Hyoung Seok Kim, Su Jin Yoo, et al.
Scientific Reports|February 25, 2022
Neovascular age-related macular degeneration in which exudation predominantly occurs as a subretinal fluid during anti-vascular endothelial growth factor treatmentHan Joo Cho, Mi Yeon Song, Wontae Yoon, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 27, 2017
Effect of Epiretinal Membranes on Antivascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular DegenerationHan Joo Cho, Jae Min Kim, Hyoung Seok Kim, et al.
Scientific Reports|September 15, 2021
Author Correction: Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathyJihyun Yoon, Wontae Yoon, Seung Kwan Na, et al.
American Journal of Ophthalmology|April 7, 2016
Response of Pigment Epithelial Detachment to Anti-Vascular Endothelial Growth Factor Treatment in Age-Related Macular DegenerationHan Joo Cho, Kyoung Min Kim, Hyoung Seok Kim, et al.
Retina (Philadelphia, Pa.)|October 7, 2017
INTRAVITREAL AFLIBERCEPT AND RANIBIZUMAB INJECTIONS FOR TYPE 3 NEOVASCULARIZATIONHan Joo Cho, Hyun Ji Hwang, Hyoung Seok Kim, et al.
Retina (Philadelphia, Pa.)|April 24, 2013
Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for polypoidal choroidal vasculopathyHan Joo Cho, Ji Sun Baek, Dong Won Lee, et al.
American Journal of Ophthalmology|June 18, 2013
Anti-vascular endothelial growth factor monotherapy in the treatment of submacular hemorrhage secondary to polypoidal choroidal vasculopathyHan Joo Cho, Kyung Min Koh, Hyoung Seok Kim, et al.
Scientific Reports|June 9, 2021
Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathyJihyun Yoon, Wontae Yoon, Seung Kwan Na, et al.
Acta Ophthalmologica|September 30, 2020
Progression of macular atrophy in patients undergoing anti-vascular endothelial growth factor therapy for neovascular age-related macular degenerationHan Joo Cho, Sang Min Park, Jaemin Kim, et al.
Korean Journal of Ophthalmology : KJO|August 21, 2022
Immediate Vitrectomy for Acute Endophthalmitis in Patients with a Visual Acuity of Hand Motion or BetterJaemin Kim, Hyoung Seok Kim, Su Jin Yoo, et al.
Scientific Reports|February 25, 2022
Neovascular age-related macular degeneration in which exudation predominantly occurs as a subretinal fluid during anti-vascular endothelial growth factor treatmentHan Joo Cho, Mi Yeon Song, Wontae Yoon, et al.
Pageof 7